Record growth, order book replenishment uncertain
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Gross margin guidance (50-55%) tracked; order book execution pace slower than Q1 implied 'by Q3'. No guidance explicitly withdrawn.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong Q2 execution (₹91.3 Cr revenue, +124% YoY, return to ₹6.5 Cr PAT) and gross margin expansion to 54.3% validate technology and execution capabilities. However, order book declined 21% QoQ to ₹202.2 Cr despite prior guidance implying ₹256.8 Cr execution by Q3, signaling slower-than-expected new order conversions. Large ₹20,000+ Cr fast-track procurement pipeline remains in early approval stages with no firm timelines; absence of forward guidance limits conviction.
₹91.3 Cr
Revenue · +124% YoY₹6.5 Cr
Reported PAT · +132.9% YoYExpanding
Margins · vs guidance: MixedDid the claims hold up?
Defense deliveries drove gross margin expansion from 50% to 54.3%
METGross margin 54.3% vs 50% YoY; product mix shift confirmed but no segment breakdown
Executed >50% of FY'27 opening order book in H1
OVERSTATEDOrder book fell ₹256.8 Cr to ₹202.2 Cr; H1 execution ~₹54.6 Cr (~45-47% if opening was ~₹340 Cr)
₹20,000 Cr fast-track procurement opportunities expected to accelerate Q3-Q4 orders
UnverifiedOpportunities in evaluation/RFP stage; DAC cleared ₹2.12L Cr proposals; no conversions yet this quarter
Return to profitability at PAT level
METQ2 FY26 PAT loss ₹19.6 Cr; Q2 FY27 profit ₹6.5 Cr; YoY +132.9%
Order book replenishment is key priority alongside execution
METOrder book declined 21% QoQ from ₹256.8 Cr to ₹202.2 Cr; new orders critical to sustain growth
Earnings quality
What changed since the last call
Order book trajectory softened
Downgrade₹256.8 Cr at Q1 declined to ₹202.2 Cr after Q2 execution; implies full-year delivery, not 'by Q3' as prior guidance suggested
Gross margin expanded; product mix shifted
UpgradeQ2 gross margin 54.3% vs 50% YoY; management attributes to defense mix; Q1 was 49%, suggesting sequential ₹5.3pp improvement
ZOLT Hybrid development formalized
NewUpgraded from ISR platform to combat-capable hybrid with 100-200km endurance; field trials ongoing; scale-up timeline extends into FY28
RDI funding secured for YETI
New₹151 Cr matching principal grant + ₹150 Cr debt from Technology Development Board at 4% interest; formalizes YETI as strategic multi-year investment
US JV strategy reset
WithdrawnFirst Breach JV agreement terminated (not operationalized, no capital deployed); pursuing US market independently via subsidiary and partnerships
The Q&A
Analysts pressed management on FTP quantum and timeline; management hedged citing approval dependencies. Questions on product mix, ZOLT variants, and order inflows went largely unanswered with specificity. Tone suggests analysts skeptical of FTP materialization in FY27; management defended execution track record but could not quantify near-term order conversion.
RDI funding terms — Abhijeet Singh, Systematix
AnsweredMatching principal grant structure; company contributes equally. Debt is ~10-year tenure at 4% interest. Deployment split: debt repayment, R&D, working capital, capex.
Revenue drivers — Abhijeet Singh, Systematix
PartialDefense deliveries were heaviest; cannot disclose specific product mix due to confidentiality; all platforms contributing.
ZOLT specification — Abhijeet Singh, Systematix
AnsweredTarget 100-200km endurance; early flight test phase; engineering data collection ongoing; expect dev cycle to extend into FY28 before production phase.
FTP pipeline clarity — Dipen Vakil, PhillipCapital
DodgedFragmented opportunities; some RFPs already released, others coming; timeline depends on approval cycle (varies 6 months to a year). No specific visibility.
Order book execution — Deepak Poddar, Sapphire
PartialMost will execute H2, dependent on spare supplies. New orders expected Q3-Q4 bidding cycle. Cannot ballpark inflows yet.
Combat UAV capability — Nikhil Gupta, Vaayu
AnsweredMixed strategy: partner with mature solutions, develop own where technology advantage exists. ZOLT expanding into air-launched effects, integrated with ISR.
International markets — Tushar Khurana, Peace Wealth
AnsweredNATO opportunities pursued; Middle East expansion active (Raisina visit); US: JV terminated, pursuing independently via subsidiary and partnerships; Blue SUAS certification ongoing.
DAC acquisition pipeline — Jojo Shaju, Tirhan
DodgedWon't bid all (low maturity); will explore others. Tender size varies; most exceed Vice Chief's threshold (>₹4-digit Cr). Timeline depends on AON approval.
Export and certification — Tushar Khurana, Peace Wealth
PartialTracking LC-ISR challenge; participating if suitable. Blue SUAS certification process ongoing, very involved.
Partnership strategy — Midhun James, Moat PMS
Answered4 investments in entities: Nautical Wings (carbon fiber propeller supplier); GalaxEye (drone-borne radar); TEHEAGLE (FTP platforms). Exploring technical collaboration and downstream opportunities.
Guidance
No explicit FY27 revenue target stated
LowManagement focuses on order book execution (₹202.2 Cr remaining) and FTP pipeline conversions without quantifying expected revenue
Gross margin 50-55% (from Q1 guidance, reaffirmed implicitly)
HighQ2 delivered 54.3%, tracking center of range. Dependent on product mix (defense vs civil)
EBITDA margin ~25% (implied from Q2: 25.4%)
MediumSupported by Q2 execution; subject to operating leverage and product mix
₹80-90 Cr annually under RDI funding for YETI, ZOLT, and platform development
High₹151 Cr debt + company matching; committed for ~10 years; split across R&D, capex, working capital
Risks the call surfaced
Order book replenishment
MediumOrder book fell ₹54.6 Cr (21% QoQ) to ₹202.2 Cr after Q2; execution pace insufficient to maintain 200%+ growth if FTP pipeline doesn't convert in H2 FY27
FTP pipeline timing
High₹20,000+ Cr fast-track opportunities fragmented and largely in approval/evaluation stages; no firm RFP timelines or conversion probabilities disclosed
Supply chain constraints
MediumManagement acknowledges 'persistent global supply chain constraints' and 'certain delays in customer approvals for deliveries'; could constrain H2 execution of ₹202.2 Cr order book
Product development timelines
MediumZOLT Hybrid, YETI, and combat UAV variants still in development/field trial phases; scale-up timelines extend into FY28; commercialization uncertainty
Export certification delays
LowBlue SUAS certification and NATO compliance pathways lengthy and uncertain; delays could gate international (US, NATO, Canada) revenue inflows
Management
Score 7/10. CEO articulate and detailed on technology roadmap (ZOLT, YETI, SWITCH, electronic warfare). However, evasive on product mix breakdown, FTP quantum, and order inflow timelines. CFO transparent on financial mechanics (RDI terms, capex deployment) but vague on future order conversions. Delivered strong Q2 (₹91.3 Cr, +124% YoY) and H1 (₹159.9 Cr, +200% YoY). Gross margin tracking guidance (50-55%, now 54.3%). BUT order book replenishment pace slower than prior implied; execution of ₹256.8 Cr order book extending beyond Q3. Return to profitability (+133% YoY PAT) achieved.
1 · Q3-Q4 FY27
FTP procurement RFPs expected to convert; DAC approvals recently cleared
2 · FY28
ZOLT Hybrid field trials and commercialization; YETI platform milestones with ₹151 Cr RDI support
3 · H2 FY27
Execution of ₹202.2 Cr remaining order book; fresh order inflows critical to offset depletion
Large ₹20,000+ Cr fast-track procurement pipeline remains in early approval stages with no firm timelines; absence of forward guidance limits conviction.
Informational and educational content only. Not investment advice.